Search results

Selected filters:

Analysis
Strategy

Article type

Topic

Sector

Regions

Year

2,414 results found for your search

Sort options
23 January 2020

Indian court sends conflicting signals in AstraZeneca disputes

The High Court of Delhi has taken inconsistent positions on issues of evergreening and genus/species patents in case that goes to heart of protections available to life sciences companies

21 January 2020

Vietnam's 5G ambitions put IP environment in focus

A state-run telecom's claim to be producing its own networking gear is the latest indication that there are opportunities for IP-based collaboration in a fast growing tech market

21 January 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade

16 January 2020

Viability of sham litigation suits on the line in AbbVie appeal

The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

08 January 2020

Increasing scrutiny for patent filing subsidies in China

Last year patent agencies came under scrutiny for gaming the system, and corporate IP managers say they expect tighter auditing in the year to come

07 January 2020

ITC cases were more China-focused than ever in 2019

But study by Chinese trade body shows that respondents who fight back do surprisingly well

07 January 2020

Federal Circuit delivers good news for process patent owners

A precedential decision last month makes it easier for rights holders to assert successfully against imported products

06 January 2020

Xiaomi, HP among eleventh-hour MPEG-LA HEVC licensees

Nineteen companies in all took the chance to secure rights to the portfolio before a contingent of South Korean and Japanese patent owners departed the pool last Thursday

03 January 2020

Huawei to join HEVC Advance in first major pool sign-up

Previously unaffiliated, the Chinese company is set to come on board as a licensor and licensee

20 December 2019

Jury awards $752 million in dispute over cutting-edge CAR-T technology

The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.

19 December 2019

Oblon McClelland Maier & Neustadt revealed as number one filer for the IAM/ktMINE US Patent Elite

Arlington-based firm acts for more of the companies that own the biggest US portfolios than any other, with Foley & Lardner and Harness Dickey & Pierce rounding out the top three

17 December 2019

US NPE leverages China litigation to secure Xiaomi deal

Acacia sub-licensor scored a global deal with smartphone maker as key rights neared expiration

17 December 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions

16 December 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts